IL17A and pneumococcal pneumonia: Interestingly, neutralization of IL-17A did not significantly change pulmonary pneumococcal burdens in WT mice (supplementary Fig 8C), indicating that IL-17A was produced at a functionally ineffective level in WT mice during secondary pneumococcal pneumonia.